Induced-fit mechanism for catecholamine binding to the β2-adrenergic receptor

被引:20
作者
Del Carmine, R
Molinari, P
Sbraccia, M
Ambrosio, C
Costa, T
机构
[1] Ist Super Sanita, Dept Pharmacol, I-00161 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy
关键词
D O I
10.1124/mol.66.2.356
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We engineered single and multiple mutations of serines 203, 204, and 207 in the fifth transmembrane domain of the beta(2)-adrenergic receptor, a region known to interact with hydroxyl groups of the catechol ring. Using such mutants, we measured the binding affinities of a panel of six catecholamine agonists differing only in the presence of substituents in the ethanolamine tail of the molecule. Although all ligands shared an intact catechol ring, they exhibited different losses of binding energy in response to the mutations. For all mutations, we found a clear relationship between the loss of binding caused by receptor mutation and that caused by the ligand modification. This indicates that the catechol ring and the ethanolamine tail synergistically influence their respective interactions when binding to the receptor. To verify this idea by a formal thermodynamic test, we used a double-mutant cycle analysis. We compared the effects of each receptor mutation with those induced by the modifications of the ligand's tail. Because such changes disrupt interactions occurring at different receptor domains, they should produce cumulative losses. In contrast, we found positive cooperativity between such effects. This means that the binding of each side of the catecholamine can enhance the binding of the other, through an effect that is probably propagated via a conformational change. We suggest that the agonist-binding pocket is not rigid but is dynamically formed as the ligand builds an increasing number of contacts with the receptor.
引用
收藏
页码:356 / 363
页数:8
相关论文
共 25 条
  • [1] Ambrosio C, 2000, MOL PHARMACOL, V57, P198
  • [2] β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors
    Azzi, M
    Charest, PG
    Angers, S
    Rousseau, G
    Kohout, T
    Bouvier, M
    Piñeyro, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (20) : 11406 - 11411
  • [3] Activation of the β2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6
    Ballesteros, JA
    Jensen, AD
    Liapakis, G
    Rasmussen, SGF
    Shi, L
    Gether, U
    Javitch, JA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) : 29171 - 29177
  • [4] Serine and threonine residues bend α-helices in the χ1 = g- conformation
    Ballesteros, JA
    Deupi, X
    Olivella, M
    Haaksma, EEJ
    Pardo, L
    [J]. BIOPHYSICAL JOURNAL, 2000, 79 (05) : 2754 - 2760
  • [5] Mutations inducing divergent shifts of constitutive activity reveal different modes of binding among catecholamine analogues to the β2-adrenergic receptor
    Del Carmine, R
    Ambrosio, C
    Sbraccia, M
    Cotecchia, S
    Ijzerman, AP
    Costa, T
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (07) : 1715 - 1722
  • [6] SIMULTANEOUS ANALYSIS OF FAMILIES OF SIGMOIDAL CURVES - APPLICATION TO BIOASSAY, RADIOLIGAND ASSAY, AND PHYSIOLOGICAL DOSE-RESPONSE CURVES
    DELEAN, A
    MUNSON, PJ
    RODBARD, D
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1978, 235 (02): : E97 - E102
  • [7] Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin
    Farrens, DL
    Altenbach, C
    Yang, K
    Hubbell, WL
    Khorana, HG
    [J]. SCIENCE, 1996, 274 (5288) : 768 - 770
  • [8] Agonist-induced conformational changes in the G-protein-coupling domain of the β2 adrenergic receptor
    Ghanouni, P
    Steenhuis, JJ
    Farrens, DL
    Kobilka, BK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (11) : 5997 - 6002
  • [9] Mutation of Asn293 to Asp in transmembrane helix VI abolishes agonist-induced but not constitutive activity of the β2-adrenergic receptor
    Hannawacker, A
    Krasel, C
    Lohse, MJ
    [J]. MOLECULAR PHARMACOLOGY, 2002, 62 (06) : 1431 - 1437
  • [10] NONADDITIVITY IN PROTEIN-PROTEIN INTERACTIONS
    HOROVITZ, A
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1987, 196 (03) : 733 - 735